Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Biote (BTMD) Operating Expenses (2021 - 2025)

Biote has reported Operating Expenses over the past 5 years, most recently at $4.1 million for Q4 2025.

  • Quarterly results put Operating Expenses at $4.1 million for Q4 2025, up 0.99% from a year ago — trailing twelve months through Dec 2025 was $16.6 million (up 1.21% YoY), and the annual figure for FY2025 was $16.6 million, up 1.21%.
  • Operating Expenses for Q4 2025 was $4.1 million at Biote, down from $4.3 million in the prior quarter.
  • Over the last five years, Operating Expenses for BTMD hit a ceiling of $113.7 million in Q2 2022 and a floor of $58560.0 in Q1 2021.
  • Median Operating Expenses over the past 5 years was $12.4 million (2021), compared with a mean of $17.5 million.
  • Biggest five-year swings in Operating Expenses: surged 28182.73% in 2022 and later plummeted 86.02% in 2024.
  • Biote's Operating Expenses stood at $18.5 million in 2021, then grew by 19.4% to $22.1 million in 2022, then rose by 19.19% to $26.3 million in 2023, then crashed by 84.68% to $4.0 million in 2024, then grew by 0.99% to $4.1 million in 2025.
  • The last three reported values for Operating Expenses were $4.1 million (Q4 2025), $4.3 million (Q3 2025), and $3.6 million (Q2 2025) per Business Quant data.